Nalaganje...
Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective
The European Medicines Agency (EMA) revises its guideline on minimizing risk in first‐in‐human trials to reflect changing practice and in light of a recent tragic incident.
Shranjeno v:
| izdano v: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5873368/ https://ncbi.nlm.nih.gov/pubmed/29105746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.899 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|